Juniper Pharmaceuticals Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Juniper Pharma (JNP) Tops Q3 EPS by 14c
November 10, 2015 4:32 PM ESTJuniper Pharma (NASDAQ: JNP) reported Q3 EPS of $0.09, $0.14 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $7.1 million.
For earnings history and earnings-related data on Juniper Pharma (JNP) click here.
... More